| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/13/2001 | US6200610 Coded tracer for animal feeds |
| 03/13/2001 | US6200606 Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| 03/13/2001 | US6200567 An antibody that binds to the common beta c chain of the receptor for gm-csf, il-3 and il-5 |
| 03/13/2001 | US6200559 Use of antibodies against MxA or MxB to determine levels of type I interferons in vivo |
| 03/13/2001 | US6200546 Gastrin receptor-avid peptide conjugates |
| 03/13/2001 | US6200532 Particularly prothrombin times; activated partial thromboplastin times and other clotting tests. |
| 03/13/2001 | US6200520 Sampling vessel for obtaining a cooling curve of molten metals |
| 03/13/2001 | US6200500 The control compositions comprise a reticulocyte component, a white blood cell component, a red blood cell component, a nucleated red blood cell component, a platelet component and a reticulated platelet component. |
| 03/13/2001 | US6200459 Analytical method |
| 03/13/2001 | US6200443 Gas sensor with a diagnostic device |
| 03/13/2001 | US6200277 In-vivo apparatus and methods of use for determining the effects of materials, conditions, activities, and lifestyles on blood parameters |
| 03/13/2001 | US6200275 Sample collection device with extraction sleeve |
| 03/13/2001 | US6200088 On-line monitor for detecting excessive temperatures of critical components of a turbine |
| 03/13/2001 | US6199437 Apparatus for studying the effects of flow fields imposed on a material during processing |
| 03/13/2001 | US6199361 False twist texturing machine |
| 03/13/2001 | CA2143209C Calibration medium containment system |
| 03/13/2001 | CA2053298C Continuous-use molten metal inclusion sensor |
| 03/13/2001 | CA2033776C Biosensors |
| 03/08/2001 | WO2001017076A2 Tunable laser source with integrated optical amplifier |
| 03/08/2001 | WO2001016860A2 Artificial intelligence system for genetic analysis |
| 03/08/2001 | WO2001016859A2 System and method for genomic and proteomic animal disease assessment via expression profile comparison |
| 03/08/2001 | WO2001016858A2 System and method for genomic and proteomic human disease assessment via expression profile comparison |
| 03/08/2001 | WO2001016857A2 System and method for genomic and proteomic agricultural disease assessment via expression profile comparison |
| 03/08/2001 | WO2001016642A2 Integrated opto-electronic wavelength converter assembly |
| 03/08/2001 | WO2001016608A2 Apparatus and methods of detecting and controlling twists in multicore cables |
| 03/08/2001 | WO2001016605A2 Identifying modulators of transcriptional activator protein interactions |
| 03/08/2001 | WO2001016604A1 Screening for agents modulating tgf-beta cell signaling |
| 03/08/2001 | WO2001016603A2 Analysis and treatment of body weight and eating disorders |
| 03/08/2001 | WO2001016602A1 Diagnosis of neuralgic or neuritic conditions |
| 03/08/2001 | WO2001016601A1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/08/2001 | WO2001016600A1 Method of analyzing mutual interaction between protein and molecule |
| 03/08/2001 | WO2001016599A1 Assay for detecting damage to the central nervous system |
| 03/08/2001 | WO2001016598A2 High throughput chemical profiling |
| 03/08/2001 | WO2001016597A1 In vitro transcription systems and uses |
| 03/08/2001 | WO2001016596A2 Screening for modulators of gaba b receptor activity |
| 03/08/2001 | WO2001016595A1 Method and device for counting cells in urine |
| 03/08/2001 | WO2001016593A1 Method for detecting and determining the origin of undissolved gases in liquid-filled high voltage systems and devices for carrying out said method |
| 03/08/2001 | WO2001016592A1 Apparatus and method for generating moisture standards in gases |
| 03/08/2001 | WO2001016582A1 In situ methods for measuring the release of a substance from a dosage form |
| 03/08/2001 | WO2001016575A1 Glucose biosensor |
| 03/08/2001 | WO2001016379A1 Hepatitis c virus replication inhibitors |
| 03/08/2001 | WO2001016378A2 Chromosome-wide analysis of protein-dna interactions |
| 03/08/2001 | WO2001016377A2 Diagnostics and therapeutics for osteoporosis |
| 03/08/2001 | WO2001016374A2 Methods and reagents for in situ amplification |
| 03/08/2001 | WO2001016373A2 Assaying of mitochondrial intermembrane space protein translocation |
| 03/08/2001 | WO2001016372A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 03/08/2001 | WO2001016370A1 Arrays with mask layers and methods of manufacturing same |
| 03/08/2001 | WO2001016369A2 Uv excitable fluorescent energy transfer dyes |
| 03/08/2001 | WO2001016368A1 In vitro transcription systems and uses |
| 03/08/2001 | WO2001016361A2 Method for detecting and quantifying first biopolymers that are located in a liquid |
| 03/08/2001 | WO2001016360A1 A rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 03/08/2001 | WO2001016359A2 Screen for axon viability |
| 03/08/2001 | WO2001016358A2 Method of screening for triacyglycerol hydrolase inhibitors |
| 03/08/2001 | WO2001016356A1 Method for identifying an individual at risk for vascular and cancer disease |
| 03/08/2001 | WO2001016355A2 In vitro test system for gamma-secretase from enriched membranes |
| 03/08/2001 | WO2001016352A1 Methods for encoding and sorting in vitro translated proteins |
| 03/08/2001 | WO2001016326A2 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016318A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016314A1 Iren protein, its preparation and use |
| 03/08/2001 | WO2001016304A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016292A2 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | WO2001016290A2 Dna encoding the human serine protease eos |
| 03/08/2001 | WO2001016289A2 Zymogen activation system |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016184A2 Diagnostic assay for type 2 heparin-induced thrombocytopenia |
| 03/08/2001 | WO2001016182A2 POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| 03/08/2001 | WO2001016181A2 Crystal structures of domains of receptor protein tyrosine kinases and their ligands |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016161A1 SYNTHESIS OF TEMPLATE-FIXED β-HAIRPIN LOOP MIMETICS |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016155A1 Antibodies specific for fullerenes |
| 03/08/2001 | WO2001016150A2 Nucleoside analogues |
| 03/08/2001 | WO2001016149A2 2-azapurine compounds and their use |
| 03/08/2001 | WO2001016103A1 Fused pyrrolecarboxamides: gaba brain receptor ligands |
| 03/08/2001 | WO2001015800A1 Method and device for performing operations at charged microlocations |
| 03/08/2001 | WO2001015708A1 Vaccine to control equine protozoal myeloencephalitis in horses |
| 03/08/2001 | WO2001015655A2 Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders |
| 03/08/2001 | WO2001015593A2 Compositions for reducing vascular plaque formation and methods of using same |
| 03/08/2001 | WO2001015548A1 Improvements in or relating to the production of animal feed |
| 03/08/2001 | WO2001001143A3 Attachment of biomolecule to a polymeric solid support by cycloaddition of a linker |
| 03/08/2001 | WO2000073501A3 Nucleic acid molecules with specific identification of native prpsc, their production and the use thereof |
| 03/08/2001 | WO2000070344A3 Method for increasing the efficiency of experimental fractionation in activity profiling of compound mixtures |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000065349A3 Method for determining plasminogen activator inhibitor |
| 03/08/2001 | WO2000063701A3 Microarrays of polypeptides |
| 03/08/2001 | WO2000063425A3 Compound assay using nematodes |
| 03/08/2001 | WO2000061624A8 48 human secreted proteins |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000057184A3 Screening methods based on fha domains |
| 03/08/2001 | WO2000052473A9 Radiolabeling kit and binding assay |
| 03/08/2001 | WO2000050872A3 A system for cell-based screening |
| 03/08/2001 | WO2000049410A3 Lcm (laser capture microdissection) for cellular protein analysis |
| 03/08/2001 | WO2000044932A3 Homogeneous enzymatic assay for vitamin b6 |
| 03/08/2001 | WO2000039342A3 Use of essential saccharomyces genes and polypeptides |